Cost-effectiveness analysis of a universal mass vaccination program with a PHiD-CV 2+1 schedule in Malaysia

Lignende værker

• Cost-effectiveness analysis of infant pneumococcal vaccination with PHiD-CV in Korea
  af: Zhang, Xu-Hao, et al.
  Udgivet: (2017)
• A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand
  af: Varghese, Lijoy, et al.
  Udgivet: (2018)
• Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model
  af: Delgleize, Emmanuelle, et al.
  Udgivet: (2016)
• Overall effectiveness of pneumococcal conjugate vaccines: An economic analysis of PHiD-CV and PCV-13 in the immunization of infants in Italy
  af: Castiglia, Paolo, et al.
  Udgivet: (2017)
• A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzaeprotein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and Malaysia
  af: Lim, Fong Seng, et al.
  Udgivet: (2014)